USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS

摘要

Disclosed herein are methods of treating or preventing a lung disorder comprising administering to a subject a composition comprising an agent that modulates activity and/or expression of Epithelial Membrane Protein 2 (EMP2) in an amount effective to treat or prevent the lung disorder and compositions useful in such for methods.